Pivotal Submission Data Shows Tasigna(R) Achieved Impressive Response Rates In Chronic Myeloid Leukemia Patients No Longer Helped By Gleevec(R)

Tue, 26 Dec 2006 02:00 PM EST

... New clinical data presented today demonstrated that Tasigna(R) (nilotinib) eliminated or significantly reduced the presence of blood cells containing a defective chromosome in approximately half of adult patients with a form of life-threatening leukemia who developed resistance and/or intolerance to treatment with Gleevec(R) (imatinib mesylate) tablets. [click link for full article] ...